iiinova — where your digital self keeps evolving

Philip Leung @philipleungkh.bsky.social · 10/10/2025

One of the most rewarding aspects of research @imperialmed.bsky.social is witnessing students grow into confident, curious scientists during their degrees👩🏻‍🔬🎓 Huge congratulations to our @imperialsandc.bsky.social students once again! Looking forward to seeing their exciting projects published soon😁

020

Philip Leung @philipleungkh.bsky.social · 03/06/2025

[Paper Skeet-torial] Can VOCs be used to non-invasively monitor cancer therapy response? In our latest pilot study in @natureportfolio.nature.com Scientific Reports, we explored the volatilomic signatures of mTOR inhibitor resistance in colorectal cancer. 🔗 nature.com/articles/s41... 1/n

nature.com

Volatilomic response to targeted cancer therapy in vitro - Scientific Reports

Scientific Reports - Volatilomic response to targeted cancer therapy in vitro

152

Philip Leung @philipleungkh.bsky.social · 13/12/2024

🎉Last big to-do for 2024 checked off! #PhD thesis successfully defended. ✅ Dr. Philip Leung, PhD FHEA It’s been an enjoyable and intellectually stimulating 3-year journey working with @hannagroupicl.bsky.social and @dr--stef.bsky.social🙌 @imperialsandc.bsky.social @imperialmed.bsky.social

261